Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | September 02, 2025 08:08am

Gainers

  • CARISMA Therapeutics (NASDAQ:CARM) shares moved upwards by 142.7% to $0.52 during Tuesday's pre-market session. The market value of their outstanding shares is at $8.9 million.
  • United Therapeutics (NASDAQ:UTHR) stock rose 42.45% to $434.16. The company's market cap stands at $13.7 billion.
  • Mineralys Therapeutics (NASDAQ:MLYS) shares moved upwards by 39.59% to $21.61. The company's market cap stands at $1.0 billion.
  • GlucoTrack (NASDAQ:GCTK) shares moved upwards by 37.9% to $5.82. The company's market cap stands at $3.7 million.
  • MannKind (NASDAQ:MNKD) stock rose 31.15% to $6.02. The market value of their outstanding shares is at $1.3 billion.
  • Cytokinetics (NASDAQ:CYTK) shares increased by 27.37% to $45.0. The company's market cap stands at $4.2 billion.

Losers

  • Tectonic Therapeutic (NASDAQ:TECX) stock fell 21.7% to $19.99 during Tuesday's pre-market session. The company's market cap stands at $477.9 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) stock decreased by 19.26% to $1.3. The market value of their outstanding shares is at $24.7 million.
  • Inventiva (NASDAQ:IVA) stock fell 15.51% to $5.23. The market value of their outstanding shares is at $860.9 million.
  • ALT5 Sigma (NASDAQ:ALTS) stock declined by 15.36% to $6.67. The company's market cap stands at $958.2 million.
  • Celularity (NASDAQ:CELU) shares declined by 13.19% to $3.42. The market value of their outstanding shares is at $94.3 million.
  • Canopy Growth (NASDAQ:CGC) shares decreased by 12.23% to $1.58. The company's market cap stands at $561.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADGM ALTS CARM CELU CGC CYTK GCTK IVA MLYS MNKD TECX UTHR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist